Program for sexual health screening and prevention for vulnerable women
Official title: PrEVE: Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women in the Greater Paris Region
Run by Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · NCT06996938 · Data updated 2026-11-12
This study is testing a new program to see if sexual health screenings and support can help vulnerable women in the Ile de France area who are at higher risk for HIV and other infections.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida Academic / other |
| Locations | 2 sites (Paris and 1 other locations) |
| Status | Recruiting |
| Started | March 21, 2025 |
| Main results expected | December 30, 2027 |
| Study ends | June 15, 2028 |
| Registry record updated | May 30, 2025 |
| Trial ID | NCT06996938 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this program are women aged 18 and older living in Ile de France who are in vulnerable situations, such as lacking stable housing or being occasional paid sex workers.
✕Probably not a fit
Patients who are not in vulnerable situations or those who cannot provide informed consent will not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program aims to evaluate the acceptability and impact of a sexual health screening and prevention initiative specifically designed for vulnerable women in the Ile de France region. It focuses on women who are at increased risk of HIV and other sexually transmitted infections due to social and economic vulnerabilities. The program includes rapid diagnostic tests for HIV, Hepatitis, and syphilis to identify and address health needs effectively. By engaging with this population, the initiative seeks to improve health outcomes and provide necessary support services.
Why it matters
Potential benefit: If successful, this program could significantly reduce the incidence of HIV and STIs among vulnerable women, improving their overall health and well-being.
How similar studies have gone: Other studies targeting vulnerable populations with similar screening and prevention approaches have shown promise, indicating potential for success in this initiative.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female, 18 years of age or older * Living in Ile de France * In a vulnerable situation with at least one of the following two situations: * Social/economic vulnerability (without personal residence or residence permit of less than 2 years or expiring in less than 1 year or without social security/AME/PUMA (ex CMU) * Sexual vulnerability: occasional paid sex worker * Able to understand the objectives of the study * Having been informed of the study objectives and not opposed to participating in the study. * Having signed the consent form prior to any examination being performed in the study. Exclusion Criteria: • Person protected by law, or not in a position to express their consent or subject to a measure of guardianship or safeguard of justice
Where it's running
-
Pitie-Salpetriere Hospital
Paris, France Recruiting -
IKAMBERE Association
Saint-Denis, Île-de-France Region, France Recruiting
Study contacts
- Study coordinator: Yasmine DUDOIT, Project manager
- Email: yasmine.dudoit@aphp.fr
- Phone: +33 (0)1 42 16 41 81
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.